2020 Frontiers in Cancer Immunotherapy This annual two-day meeting convenes top experts in tumor immunology, cancer genetics and computational biology to discuss innovative methods to analyze both the tumor and the host immune system and highlight the links between tumor genotype, immune phenotype and patient response. Key topics under discussion this year include tumor evolution, neoantigens, novel therapeutic targets, and mechanisms driving the emergence of resistance to current therapy. FEATURED SPEAKERS: Elizabeth Jaffee, MD, Johns Hopkins School of Medicine Elaine Mardis, PhD, The Ohio State University Robert Schreiber, PhD, Washington University School of Medicine in St. Louis Charles Swanton, FRCP, PhD, FRS, The Francis Crick Institute Catherine Wu, MD, Dana-Farber Cancer Institute and Harvard Medical School ABSTRACT DEADLINE: March 3, 2020 REGISTER: nyas.org/Immunotherapy2020 Early Bird Discount Ends: March 30, 2020 May 11-12, 2020, at the New York Academy of Sciences in New York City Read more: Post navigation Understanding Genomics and Genetic Testing in Cancer Immunotherapy Read Story COVID-19 and Cancer Immunotherapy Research: How Science from the Frontlines of Immuno-Oncology Is Helping Inform Strategies to Treat and Prevent COVID-19 Read Story
